Xia-Bin Jing

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Platinum-based anticancer agents are widely used as first-line drugs in cancer chemotherapy for various solid tumors. However, great side effects and occurrence of resistance remain as the major drawbacks for almost all the platinum drugs developed. To conquer these problems, new strategies should be adopted for platinum drug based chemotherapy. Modern(More)
  • 1